Improving Care Quality for Metabolic Dysfunction-associated Steatotic Liver Disease Through a Structured Yogic...

Area of Science:

• Hepatology
• Metabolic Disorders
• Integrative Medicine

Background:

• Metabolic dysfunction-associated steatotic liver disease (MASLD) is a prevalent global condition.
• MASLD is closely associated with obesity, hypertension, type 2 diabetes, and dyslipidemia.
• Yoga offers a comprehensive approach to enhance liver function, metabolic health, and mental well-being.

Purpose of the Study:

• To assess the efficacy of a 60-minute yoga module in improving liver health and metabolic markers in MASLD patients.
• To evaluate the impact of yoga on hepatic steatosis and associated metabolic parameters.
• To determine yoga's potential as a complementary therapy for MASLD.

Main Methods:

• An open-label, randomized controlled trial involving 72 MASLD patients.
• Participants received either a 60-minute online yoga module (5 days/week for 3 months) or standard care.
• Assessments included liver fat (ultrasound), liver enzymes (SGPT, SGOT), HbA1c, lipid profile, BMI, blood pressure, mental health, and quality of life.

Main Results:

• The study is designed to evaluate improvements in hepatic steatosis.
• Metabolic and psychosocial parameters will be assessed post-intervention.
• The trial aims to quantify the effects of yoga on MASLD indicators.

Conclusions:

• This trial will offer evidence regarding yoga's utility as an adjunctive therapy in MASLD management.
• Findings may support the integration of yoga into standard MASLD care protocols.
• Yoga's role in improving metabolic and liver health in MASLD patients will be elucidated.